Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cell Physiol ; 182(2): 281-9, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10623892

RESUMO

Plasminogen activator inhibitor type 2 (PAI-2) is a serine proteinase inhibitor (serpin), present in high quantities in stratified squamous epithelia. Detergent extracts of human epidermis or cultured keratinocytes contain primarily active, nonglycosylated PAI-2. In keratinocytes, the vast majority of PAI-2 is retained within the cell, supporting the hypothesis that PAI-2 may serve specific intracellular function(s) through interaction with an unknown cytoplasmic proteinase. During interaction with the target proteinase, cleavage of PAI-2 within its reactive site loop leads to the formation of a more stable, "relaxed" conformation (PAI-2r). Using a monoclonal antibody specific for PAI-2r, we demonstrate here that PAI-2r is present in keratinocytes of the granular and basal layers of normal human epidermis. In addition, PAI-2r is detectable in cultured human epidermal keratinocytes, where it is concentrated in a detergent-insoluble fraction within differentiating cells. These data provide evidence for the presence of an endogenous, keratinocyte-derived proteinase that constitutively cleaves intracellular PAI-2 in normal human epidermal keratinocytes. Cleavage of PAI-2 by this proteinase may reflect specific intracellular action of PAI-2 in normal cells. Finally, we demonstrate that a commercially available anti-PAI-2 monoclonal antibody (#3750, American Diagnostica, Greenwich, CT), under native experimental conditions, preferentially recognizes the uncleaved, active form of PAI-2 and does not efficiently detect PAI-2r.


Assuntos
Epiderme/metabolismo , Membranas Intracelulares/metabolismo , Queratinócitos/metabolismo , Inibidor 2 de Ativador de Plasminogênio/química , Inibidor 2 de Ativador de Plasminogênio/metabolismo , Anticorpos/imunologia , Detergentes/farmacologia , Resistência a Medicamentos , Endopeptidases/metabolismo , Células Epidérmicas , Epiderme/efeitos dos fármacos , Humanos , Membranas Intracelulares/efeitos dos fármacos , Queratinócitos/efeitos dos fármacos , Conformação Molecular , Inibidor 2 de Ativador de Plasminogênio/imunologia , Inibidor 2 de Ativador de Plasminogênio/fisiologia , Valores de Referência
2.
Histochem Cell Biol ; 110(6): 559-69, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9860254

RESUMO

In stratified squamous epithelia a critical balance among cell proliferation, differentiation, and death must be maintained in order for these tissues to fulfill their barrier function. Previous studies have demonstrated that plasminogen activator inhibitor 2 (PAI-2) is a product of differentiating epidermal keratinocytes, suggesting a role for this inhibitor during squamous differentiation. Furthermore, in certain tumor cell lines, overexpression of PAI-2 confers resistance to the induction of programmed cell death, suggesting cytoprotective function(s). In the present study we demonstrate that PAI-2 mRNA and protein are constitutively and uniquely expressed in differentiating cells of murine stratified squamous epithelia, including epidermis, esophagus, vagina, oral mucosa, and tongue. PAI-2 immunohistochemical localization patterns suggest a predominantly cytosolic distribution, consistent with biochemical identification of the major PAI-2 species as a 43-kDa, presumably non-glycosylated protein. Functional analysis shows that the majority of epithelial PAI-2 is active. In contrast to the high levels of PAI-2 expression in stratified squamous epithelia, little or no PAI-2 is detectable in simple epithelia. These findings suggest that epithelial PAI-2 may mediate inhibition of intracellular proteinases associated with events during terminal differentiation and death that are unique to stratified squamous epithelia.


Assuntos
Células Epiteliais/metabolismo , Inibidor 2 de Ativador de Plasminogênio/metabolismo , Inibidores de Serina Proteinase/metabolismo , Animais , Animais Recém-Nascidos , Diferenciação Celular , Epiderme/metabolismo , Esôfago/metabolismo , Feminino , Técnicas Imunoenzimáticas , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos SENCAR , Mucosa Bucal/metabolismo , Inibidor 2 de Ativador de Plasminogênio/genética , RNA Mensageiro/biossíntese , Inibidores de Serina Proteinase/genética , Língua/metabolismo , Vagina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...